Results 11 to 20 of about 41,455 (247)

Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. [PDF]

PLoS ONE, 2009
BACKGROUND: Identification of high-risk populations for serious infection due to S. pneumoniae will permit appropriately targeted prevention programs. METHODS: We conducted prospective, population-based surveillance for invasive pneumococcal disease and ...
Agron Plevneshi, Tomislav Svoboda, Irene Armstrong, Gregory J Tyrrell, Anna Miranda, Karen Green, Donald Low, Allison McGeer, Toronto Invasive Bacterial Diseases Network   +8 more
doaj   +3 more sources

Invasive pneumococcal disease in Greenland [PDF]

International Journal of Circumpolar Health, 2004
The Inuit of Alaska and Canada have a higher incidence of invasive pneumococcal disease than non-inuit. The purpose of the present study was to evaluate incidence and outcome of these infections in Greenland with special reference to pneumococcal serotypes.Retrospective study of invasive pneumococcal infections in Greenland in the period 1996-2002 ...
Christiansen, J., Poulsen, P., Ladefoged, K.   +2 more
openaire   +4 more sources

Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. [PDF]

PLoS ONE, 2014
Since nasopharyngeal carriage of pneumococcus precedes invasive pneumococcal disease, characteristics of carriage isolates could be incorrectly assumed to reflect those of invasive isolates.
In Ho Park, K Aaron Geno, Logan K Sherwood, Moon H Nahm, Bernard Beall   +4 more
doaj   +1 more source

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis

Infectious Disease Reports, 2023
Streptococcus pneumonia (S. pneumoniae, Pneumococcus) is a major cause of childhood morbidity and mortality worldwide. The most common presentations of invasive pneumococcal disease (IPD) in children include bacteremic pneumonia, meningitis, and ...
Ioanna Papadatou, Angeliki Moudaki, Anastasia Mentessidou, Dimitrios Tsakogiannis, Elissavet Georgiadou, Vana Spoulou   +5 more
doaj   +1 more source

Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling. [PDF]

PLoS ONE, 2014
This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive ...
Elisabetta De Cao, Alessia Melegaro, Rogier Klok, Maarten Postma   +3 more
doaj   +1 more source

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

The Lancet Global Health, 2021
Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine ...
Naor Bar-Zeev, PhD, Todd D Swarthout, MSc, Dean B Everett, ProfPhD, Maaike Alaerts, PhD, Jacquline Msefula, BSc, Comfort Brown, Dipl, Sithembile Bilima, BSc, Jane Mallewa, MD, Carina King, PhD, Anne von Gottberg, ProfPhD, Jennifer R Verani, MD, Cynthia G Whitney, MD, Charles Mwansambo, FRCPCH, Stephen B Gordon, ProfPhD, Nigel A Cunliffe, ProfPhD, Neil French, ProfPhD, Robert S Heyderman, ProfPhD   +16 more
doaj   +1 more source

Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis

Scientific Reports, 2021
Risk factors associated with mortality in invasive pneumococcal disease remain unclear. The present work is a meta-analysis of studies that enrolled only patients with invasive pneumococcal disease and reported on mortality.
Hao Chen, Hiromi Matsumoto, Nobuyuki Horita, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko   +5 more
doaj   +1 more source

Integrated genomic analysis of antibiotic resistance and virulence determinants in invasive strains of Streptococcus pneumoniae

Frontiers in Cellular and Infection Microbiology, 2023
IntroductionStreptococcus pneumoniae is an important human pathogen that may cause severe invasive pneumococcal diseases (IPDs) in young children and the elderly.
Lin Liu, Yanfei Wang, Yanfei Wang, Yanfei Wang, Lihong Ge, Dongping Hu, Xi Xiang, Ying Fu, Ying Fu, Jun Lu, Xi Li, Yunsong Yu, Yunsong Yu, Yunsong Yu, Yuexing Tu, Yuexing Tu, Xueqing Wu, Xueqing Wu, Xueqing Wu   +18 more
doaj   +1 more source

Changes in the Features of Invasive Pneumococcal Disease after Introduction of the Seven-valent Pneumococcal Conjugate Vaccine in a Regional Core Hospital of Kochi, Japan [PDF]

, 2015
Since the introduction of the seven-valent pneumococcal conjugate vaccine (PCV7) in 2007, invasive pneumococcal disease has declined, but the incidence of Streptococcus pneumoniae serotype 19A has risen worldwide.
Akane Kanazawa, Chiho Tokorodani, Hidehiko Maruyama, Hirokazu Watanabe, Hiroyuki Miyahara, Kiyoshi Kikkawa, Mari Miyazawa, Ritsuo Nishiuchi, Yuka Iwasaki, Yusei Nakata, Yusuke Shigemitsu   +10 more
core   +1 more source

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.

PLoS ONE, 2022
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes.
Sweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, Rebecca R Young, Mohamed Z Patel, Tiny Mazhani, Sefelani Boiditswe, Tirayaone Leburu, Kwana Lechiile, Tonya Arscott-Mills, Andrew P Steenhoff, Kristen A Feemster, Samir S Shah, Coleen K Cunningham, Stephen I Pelton, Matthew S Kelly   +15 more
doaj   +3 more sources